Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy.
Diabetes mellitus and heart failure (HF), both of which are associated with high rates of adverse cardiovascular outcomes, commonly coexist. Given the marked increases in diabetes prevalence in developed countries, the proportion of the population with both conditions is likely to increase substantially. This article reviews the epidemiology of HF and diabetes, the mechanisms whereby diabetes causes HF, and the pharmacotherapy of both HF and diabetes. Specific challenges in treating patients with both HF and diabetes are also addressed.
Masoudi
Frederick A
FA
Division of Cardiology, Department of Medicine, Denver Health Medical Center, Denver, Colorado 80204, USA. fred.masoudi@uchsc.edu
Inzucchi
Silvio E
SE
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007333:Insulin Resistance / Q000502:physiology; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D000451:Mineralocorticoid Receptor Antagonists